Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 10, 2020

SELL
$8.64 - $11.87 $111,576 - $153,289
-12,914 Closed
0 $0
Q1 2020

Apr 13, 2020

SELL
$9.11 - $14.42 $89,123 - $141,070
-9,783 Reduced 43.1%
12,914 $124,000
Q4 2019

Jan 15, 2020

SELL
$13.16 - $15.96 $19,134 - $23,205
-1,454 Reduced 6.02%
22,697 $327,000
Q3 2019

Nov 01, 2019

BUY
$11.26 - $16.48 $271,940 - $398,008
24,151 New
24,151 $363,000

Others Institutions Holding OPNT

About OPIANT PHARMACEUTICALS, INC.


  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.